Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies

OBJECTIVES: COVID-19 patients affected by haematological malignancies have a more severe course of the disease and higher mortality, prompting for effective prophylaxis. The present study aims to evaluate the humoral response after mRNA vaccination as well as the impact of a third vaccine dose in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gressens, Simon B., Fourati, Slim, Le Bouter, Anne, Le Bras, Fabien, Dupuis, Jehan, Hammoud, Mohammad, El Gnaoui, Taoufik, Gounot, Romain, Roulin, Louise, Belhadj, Karim, Haioun, Corinne, Gallien, Sébastien, Melica, Giovanna, Lemonnier, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897197/
https://www.ncbi.nlm.nih.gov/pubmed/35259530
http://dx.doi.org/10.1016/j.cmi.2022.02.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897197/
https://www.ncbi.nlm.nih.gov/pubmed/35259530
http://dx.doi.org/10.1016/j.cmi.2022.02.029

Ejemplares similares